These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15358993)

  • 1. Vigabatrin and tiagabine might have antipanic properties.
    Zwanzger P; Rupprecht R
    J Psychopharmacol; 2004 Sep; 18(3):440. PubMed ID: 15358993
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticonvulsants as anxiolytics, part 1: tiagabine and other anticonvulsants with actions on GABA.
    Stahl SM
    J Clin Psychiatry; 2004 Mar; 65(3):291-2. PubMed ID: 15096065
    [No Abstract]   [Full Text] [Related]  

  • 3. Questionable tolerability of tiagabine in generalized anxiety disorder.
    Spielmans GI
    J Clin Psychopharmacol; 2009 Jun; 29(3):314. PubMed ID: 19440099
    [No Abstract]   [Full Text] [Related]  

  • 4. Anxiolytic effects of vigabatrin in panic disorder.
    Zwanzger P; Baghai T; Boerner RJ; Möller HJ; Rupprecht R
    J Clin Psychopharmacol; 2001 Oct; 21(5):539-40. PubMed ID: 11593085
    [No Abstract]   [Full Text] [Related]  

  • 5. Pre-clinical studies with the GABAergic compounds vigabatrin and tiagabine.
    Sills GJ
    Epileptic Disord; 2003 Mar; 5(1):51-6. PubMed ID: 12773297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of tiagabine augmentation for treatment-resistant anxiety disorders: a case series.
    Schwartz TL
    Psychopharmacol Bull; 2002; 36(2):53-7. PubMed ID: 12397840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vigabatrin and tiagabine are pharmacologically different drugs. A pre-clinical study.
    Sills GJ; Butler E; Thompson GG; Brodie MJ
    Seizure; 1999 Oct; 8(7):404-11. PubMed ID: 10600581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New antiepileptic drugs.
    Vajda FJ
    J Clin Neurosci; 2000 Mar; 7(2):88-101. PubMed ID: 10844790
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabine, and topiramate.
    Angehagen M; Ben-Menachem E; Rönnbäck L; Hansson E
    Neurochem Res; 2003 Feb; 28(2):333-40. PubMed ID: 12608706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different effects of GABAergic anticonvulsants on 4-aminopyridine-induced spontaneous GABAergic hyperpolarizations of hippocampal pyramidal cells--implication for their potency in migraine therapy.
    Leniger T; Wiemann M; Bingmann D; Hufnagel A; Bonnet U
    Cephalalgia; 2000 Jul; 20(6):533-7. PubMed ID: 11075835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiepileptic action induced by a combination of vigabatrin and tiagabine.
    Fueta Y; Kunugita N; Schwarz W
    Neuroscience; 2005; 132(2):335-45. PubMed ID: 15802187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies.
    Pollack MH; Tiller J; Xie F; Trivedi MH
    J Clin Psychopharmacol; 2008 Jun; 28(3):308-16. PubMed ID: 18480688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic and pharmacokinetic interaction profiles of levetiracetam in combination with gabapentin, tiagabine and vigabatrin in the mouse pentylenetetrazole-induced seizure model: an isobolographic analysis.
    Dudra-Jastrzebska M; Andres-Mach MM; Sielski M; Ratnaraj N; Patsalos PN; Czuczwar SJ; Luszczki JJ
    Eur J Pharmacol; 2009 Mar; 605(1-3):87-94. PubMed ID: 19168049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tiagabine for epilepsy.
    Med Lett Drugs Ther; 1998 Apr; 40(1024):45-6. PubMed ID: 9580745
    [No Abstract]   [Full Text] [Related]  

  • 15. Tiagabine in anxiety disorders.
    Schwartz TL; Nihalani N
    Expert Opin Pharmacother; 2006 Oct; 7(14):1977-87. PubMed ID: 17020423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isobolographic characterization of interactions between vigabatrin and tiagabine in two experimental models of epilepsy.
    Luszczki JJ; Czuczwar SJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):529-38. PubMed ID: 17204358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1) inhibitor, coincide with a decrease in HPA system activity in C57BL/6 mice.
    Thoeringer CK; Erhardt A; Sillaber I; Mueller MB; Ohl F; Holsboer F; Keck ME
    J Psychopharmacol; 2010 May; 24(5):733-43. PubMed ID: 19346277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 'number needed to treat' with levetiracetam (LEV): comparison with the other new antiepileptic drugs (AEDs).
    van Rijckevorsel K; Boon PA
    Seizure; 2002 Apr; 11 Suppl A():235-6. PubMed ID: 12185762
    [No Abstract]   [Full Text] [Related]  

  • 19. Tiagabine.
    Leach JP; Brodie MJ
    Lancet; 1998 Jan; 351(9097):203-7. PubMed ID: 9449883
    [No Abstract]   [Full Text] [Related]  

  • 20. Tiagabine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy.
    Adkins JC; Noble S
    Drugs; 1998 Mar; 55(3):437-60. PubMed ID: 9530548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.